On November 24, 2016, Mr. Roy Wayne Erwin, resigned from Oncologix Tech, Inc.'s Board of Directors and has resigned as the Chief Executive Officer. Mr. Erwin will remain with the company and will serve as President of the company's operating subsidiaries and will work in that capacity to focus his efforts to expand client base and various product lines. On November 24, 2016, the company appointed Mr. Michael A. Kramarz as Chairman of the Board of Directors and as the Chief Executive Officer.

Mr. Harold Halman is appointed as the Chief Operating Officer and appointed to the company's Board of Directors. Mr. Kramarz, has been with the company since 2002 and along with Mr. Halman will continue to work with Mr. Erwin to expand the company's foot-print to increase Shareholder value.